Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
In a major study, people using Wegovy (semaglutide) lost an average of 15% of their body weight over 68 weeks compared to those who didn't use the medication
Semaglutide is een medicijn dat oorspronkelijk werd ontwikkeld als diabetes middel afvallen, maar inmiddels wordt erkend als een van de meest effectieve nieuwe afslankmiddelen
The vast majority buy them privately because the NHS has restricted treatment to the most obese patients
Semaglutide was generally well tolerated, with just two severe adverse events possibly related to treatment
Second, no or only mild heterogeneity was found in any of the meta-analyses conducted in the present study
US$ 27.28
US$ 23.15
US$ 27.18
US$ 21.88
US$ 26.03
US$ 20.83
